Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IMI International's Cholesterol 1,2,3

This article was originally published in The Gray Sheet

Executive Summary

Rapid, non-invasive skin cholesterol test will be launched in Canada by the end of the year, following receipt of a medical device license by Health Canada, firm announces Jan. 29. Three-minute test uses a hand-held spectrophotometer to determine color change in a drop of liquid held in the palm of the hand. Toronto firm will submit a 510(k) application to FDA in the next several months and is negotiating with potential distributors to doctors' offices, pharmacies, clinics and laboratories. A home version of the test will probably be available in 2003

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014444

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel